This inventor holds 1 USPTO granted patent and 2 published patent applications and 3 EPO patents. Top assignee: Clinical Genomics Pty. Ltd.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Innovations in Colorectal Cancer Screening by Snigdha Gaur
Introduction
Snigdha Gaur is an accomplished inventor based in New South Wales, Australia. She has made significant contributions to the field of medical diagnostics, particularly in the area of colorectal cancer screening. Her innovative approach aims to improve the accuracy of cancer classification, which is crucial for effective treatment and monitoring.
Latest Patents
Snigdha Gaur holds a patent for a method of screening for colorectal cancer. This invention relates to determining the probabilities of classifying a neoplasm into various neoplastic categories. Specifically, it focuses on classifying large intestine neoplasms into categories such as adenoma, stage I, stage II, stage III, or stage IV. The method involves screening for changes in the methylation levels of a panel of gene markers, including BCAT1, IKZF1, IRF4, GRASP, and CAHM. This innovative method is particularly useful for diagnosing and monitoring colorectal neoplasms, including colorectal adenocarcinosis. She has 1 patent to her name.
Career Highlights
Snigdha Gaur is associated with Clinical Genomics Pty. Ltd., where she continues to work on advancing cancer diagnostics. Her research and inventions have the potential to significantly impact patient outcomes by providing more accurate diagnostic tools.
Collaborations
Some of her notable coworkers include Lawrence Charles Lapointe and Susanne Kartin Pedersen. Their collaborative efforts contribute to the ongoing research and development in the field of genomics and cancer screening.
Conclusion
Snigdha Gaur's innovative work in colorectal cancer screening exemplifies the importance of advancements in medical diagnostics. Her contributions are paving the way for improved cancer detection and treatment strategies.